The Anglo-Swedish laboratory will not be able to keep its commitments to Europe.
AstraZeneca has informed the European Commission that it would not be able to initially deliver the agreed volumes of its COVID-19 vaccine to the EU, German newspaper Bild reported on Friday, citing sources within the laboratory. Anglo-Swedish.
This vaccine has not yet been approved in the EU. The European Medicines Agency (EMA) is due to rule next Friday.
Contacted by Reuters, a spokesperson for AstraZeneca said he had no immediate comment.